Understanding Daily Fluctuations in Self-Regulation
Completed
Conditions studied: Impulsive Behavior, Self-Regulation
In brief
Understanding Daily Fluctuations in Self-Regulation, also known as the Digital Marshmallow Test (DMT), is a collaboration by Northwell Health, Cornell Tech, and Sage Bionetworks. Funded by the Robert Wood Johnson Foundation, this is a pioneering study to advance the science in identifying and helping individuals who act on short-term temptations, despite long-term consequences. Using Apple's ResearchKit(™) and Android's ResearchStack applications, the Digital Marshmallow Test will leverage the powerful capabilities of the smartphone to examine impulsivity using a range of game-like tasks and sensor capabilities within the mobile phone. Across studies, more impulsive individuals are significantly more likely to suffer from obesity, Type II Diabetes, substance abuse, gambling problems, suicidal behaviors, and increased criminality among many other problems. Early self-report studies reveal a relationship between the inability to delay gratification and different patterns of mobile phone use. This will be the first study to develop non-invasive mobile methods to identify and help those at greatest risk for impulsive responding before serious problems occur.
Key facts
- Study ID
- NCT03006653
- Run by
- Northwell Health
- People needed
- 116
- Starts
- 2017-01-01
- Expected to finish
- 2018-01-01
- Last updated by the study team
- 2018-01-24
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- be fluent and able to read in English at the eighth grade level (self-report and consent form quiz),
- be between the ages of 18 and 75 (self-report, age in demographics),
- be willing to provide informed consent, and
- own a mobile smartphone (iOS or Android) and are willing to receive and respond to text messages.
You may not qualify if…
- are pregnant or breast feeding,
- present with significant substance use which is defined as greater than once weekly use in the past month (for any substance other than alcohol, nicotine or caffeine) or greater than 21 standard alcoholic drinks per week for women and 24 for men,
- present with a serious psychiatric illness or suicide risk as measured by previous inpatient treatment, medications for psychosis or recent suicidality; a current self-reported or clinician determined diagnosis of Major Depression or past or present bipolar disorder, delusional disorder or schizophrenia, and/or
- are unable to understand research study procedures as evidenced a score of less than 4 out of 5 on the consent form quiz.
Where it is running
- Center for Addiction Services and Personalized Interventions Research (CASPIR) — Great Neck, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.